RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 146 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $187,818,279 | +0.2% | 24,551,409 | -2.2% | 0.17% | +7.5% |
Q2 2023 | $187,479,296 | +11.8% | 25,097,630 | -0.2% | 0.16% | +5.3% |
Q1 2023 | $167,653,985 | -12.4% | 25,135,530 | +1.3% | 0.15% | -24.1% |
Q4 2022 | $191,368,754 | -16.7% | 24,820,850 | +14.9% | 0.20% | -16.0% |
Q3 2022 | $229,767,000 | +30.6% | 21,594,693 | -0.1% | 0.24% | +31.7% |
Q2 2022 | $175,871,000 | +11.7% | 21,605,685 | -1.7% | 0.18% | +63.6% |
Q1 2022 | $157,388,000 | -58.5% | 21,981,604 | -0.6% | 0.11% | -47.1% |
Q4 2021 | $378,969,000 | -25.3% | 22,123,155 | +0.3% | 0.21% | -21.8% |
Q3 2021 | $507,632,000 | -24.9% | 22,061,374 | +19.1% | 0.27% | -19.1% |
Q2 2021 | $676,017,000 | – | 18,521,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |